Lawrence L. Pelletier

1.3k total citations · 1 hit paper
21 papers, 1.0k citations indexed

About

Lawrence L. Pelletier is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Lawrence L. Pelletier has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 4 papers in Infectious Diseases and 4 papers in Pharmacology. Recurrent topics in Lawrence L. Pelletier's work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Parasites and Host Interactions (4 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Lawrence L. Pelletier is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (4 papers), Parasites and Host Interactions (4 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Lawrence L. Pelletier collaborates with scholars based in United States and Canada. Lawrence L. Pelletier's co-authors include Robert G. Petersdorf, David T. Durack, Robert R. Tight, D T Durack, Sarah Johnston, F. A. Neva, Albert A. Gam, M B Coyle, Thomas B. Nutman and Clare Maxwell and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Clinical Infectious Diseases.

In The Last Decade

Lawrence L. Pelletier

21 papers receiving 868 citations

Hit Papers

INFECTIVE ENDOCARDITIS 1977 2026 1993 2009 1977 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence L. Pelletier United States 15 582 338 272 162 145 21 1.0k
C. Strady France 15 666 1.1× 453 1.3× 314 1.2× 62 0.4× 317 2.2× 44 1.2k
Tânia Mara Varejão Strabelli Brazil 17 670 1.2× 285 0.8× 233 0.9× 135 0.8× 205 1.4× 72 1.0k
Patricia Pavèse France 24 644 1.1× 468 1.4× 209 0.8× 79 0.5× 251 1.7× 113 1.6k
E Soriano Spain 18 770 1.3× 641 1.9× 178 0.7× 51 0.3× 306 2.1× 55 1.5k
C. Arvieux France 23 684 1.2× 648 1.9× 192 0.7× 94 0.6× 519 3.6× 102 1.7k
Pablo Martín‐Rabadán Spain 26 1.0k 1.7× 586 1.7× 428 1.6× 177 1.1× 174 1.2× 90 2.0k
Arístides de Alarcón Spain 19 635 1.1× 464 1.4× 305 1.1× 94 0.6× 211 1.5× 66 968
H A Gallis United States 16 666 1.1× 500 1.5× 101 0.4× 37 0.2× 91 0.6× 22 1.0k
Aba Mahamat France 22 330 0.6× 495 1.5× 251 0.9× 216 1.3× 237 1.6× 61 1.4k
Inger Julander Sweden 21 930 1.6× 580 1.7× 288 1.1× 33 0.2× 199 1.4× 63 1.4k

Countries citing papers authored by Lawrence L. Pelletier

Since Specialization
Citations

This map shows the geographic impact of Lawrence L. Pelletier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence L. Pelletier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence L. Pelletier more than expected).

Fields of papers citing papers by Lawrence L. Pelletier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence L. Pelletier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence L. Pelletier. The network helps show where Lawrence L. Pelletier may publish in the future.

Co-authorship network of co-authors of Lawrence L. Pelletier

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence L. Pelletier. A scholar is included among the top collaborators of Lawrence L. Pelletier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence L. Pelletier. Lawrence L. Pelletier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Anthony, Ryan Murchie, Chong Jiang, et al.. (2015). RNA Interference Screen to Identify Kinases That Suppress Rescue of ΔF508-CFTR*. Molecular & Cellular Proteomics. 14(6). 1569–1583. 23 indexed citations
2.
Neva, F. A., Albert A. Gam, Clare Maxwell, & Lawrence L. Pelletier. (2001). Skin test antigens for immediate hypersensitivity prepared from infective larvae of Strongyloides stercoralis.. American Journal of Tropical Medicine and Hygiene. 65(5). 567–572. 16 indexed citations
3.
Pelletier, Lawrence L.. (1998). TREATMENT OF RESPIRATORY TRACT INFECTIONS. Infectious Diseases in Clinical Practice. 7(Supplement 5). S316–S323. 1 indexed citations
4.
Johnston, Sarah & Lawrence L. Pelletier. (1997). Enhanced Hepatotoxicity of Acetaminophen in the Alcoholic Patient: Two Case Reports and a Review of the Literature. Medicine. 76(3). 185–191. 31 indexed citations
5.
Pelletier, Lawrence L.. (1994). Cefprozil versus Cefaclor in the Treatment of Bronchitis in the Elderly. Clinical Drug Investigation. 8(5). 263–270. 3 indexed citations
6.
Pelletier, Lawrence L., et al.. (1992). A comparison of Macrobid (nitrofurantoin monohydrate/macrocrystals) and Macrodantin (nitrofurantoin macrocrystals) in the treatment of acute episodes of uncomplicated lower urinary tract infections. Advances in Therapy. 9(1). 32–45. 5 indexed citations
7.
Pelletier, Lawrence L.. (1992). Review of the Experience with Cefprozil for the Treatment of Lower Respiratory Tract Infections. Clinical Infectious Diseases. 14(Supplement_2). S238–S243. 12 indexed citations
8.
Pelletier, Lawrence L., et al.. (1989). The Autopsy. Journal of General Internal Medicine. 4(4). 300–303. 19 indexed citations
9.
Pelletier, Lawrence L., et al.. (1988). Diagnosis and Evaluation of Treatment of Chronic Strongyloidiasis in Ex-Prisoners of War. The Journal of Infectious Diseases. 157(3). 573–576. 33 indexed citations
11.
Pelletier, Lawrence L., et al.. (1985). Chronic strongyloidiasis in Vietnam veterans. The American Journal of Medicine. 78(1). 139–140. 35 indexed citations
12.
Pelletier, Lawrence L.. (1985). Hospital Usage of Parenteral Antimicrobial Agents: A Gradated Utilization Review and Cost Containment Program. Infection Control. 6(6). 226–230. 37 indexed citations
13.
Pelletier, Lawrence L.. (1984). Lack of reproducibility of macrodilution MBCs for Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 26(6). 815–818. 17 indexed citations
14.
Pelletier, Lawrence L.. (1984). Chronic Strongyloidiasis in World War II Far East Ex-Prisoners of War. American Journal of Tropical Medicine and Hygiene. 33(1). 55–61. 114 indexed citations
15.
Pelletier, Lawrence L., et al.. (1984). Urinary Tract Infections with Antibiotic Resistant Organisms in Catheterized Nursing Home Patients. Infection Control. 5(4). 173–176. 82 indexed citations
16.
Pelletier, Lawrence L., M B Coyle, & Robert G. Petersdorf. (1978). Dextran Production as a Possible Virulence Factor in Streptococcal Endocarditis. Experimental Biology and Medicine. 158(3). 415–420. 23 indexed citations
17.
Pelletier, Lawrence L. & Robert G. Petersdorf. (1977). INFECTIVE ENDOCARDITIS. Medicine. 56(4). 287–314. 352 indexed citations breakdown →
18.
Pelletier, Lawrence L.. (1976). Disseminated Intravascular Coagulation and Hepatic Necrosis. JAMA. 235(11). 1144–1144. 16 indexed citations
19.
Pelletier, Lawrence L., D T Durack, & Robert G. Petersdorf. (1975). Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis.. Journal of Clinical Investigation. 56(2). 319–330. 73 indexed citations
20.
Durack, David T., Lawrence L. Pelletier, & Robert G. Petersdorf. (1974). Chemotherapy of Experimental Streptococcal Endocarditis. Journal of Clinical Investigation. 53(3). 829–833. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026